RESUMO
Thiamine monophosphatase (TMPase) has been selectively localized in small dorsal root ganglion cells and in their central and peripheral terminals. Light microscopic localization of TMPase, and its alterations due to transganglionic effects, are identical with those of fluoride-resistant acid phosphatase (FRAP), but are not contaminated by the ubiquitous lysosomal reaction inevitable in trivial acid phosphatase-stained sections. TMPase is inhibited by 0.1 mM NaF, which is slightly less than the concentration needed to inhibit FRAP (0.2-0.4 mM). It is assumed that TMPase and FRAP are identical enzymes. In the perikaryon of small dorsal root ganglion cells, TMPase is located in the cisterns of the endoplasmic reticulum and in the Golgi apparatus. The central terminals of these cells are scalloped (sinusoid) axon terminals, surrounded by membrane-bound TMPase activity. Central terminals outline substantia gelatinosa Rolandi throughout the spinal cord, as well as the analogous nucleus spinalis trigemini in the medulla. TMPase-active central terminals outline "faisceau de la corne postérieure" in the sacral cord, as well as Lissauer's tract in the thoracic, upper lumbar, and sacral segments, and the paratrigeminal nucleus and the terminal (sensory) nucleus of the ala cinerea in the brainstem. Peripheral terminals displaying TMPase activity are fine nerve plexuses of C fibers. The TMPase activity of the central terminals disappears after dorsal rhizotomy in the course of Wallerian degeneration, and is depleted in the course of transganglionic degenerative atrophy (after transection of the related peripheral sensory nerve). TMPase is an outstanding genuine marker for the study of transganglionic regulation in Muridae.
Assuntos
Gânglios Espinais/enzimologia , Neurônios Aferentes/enzimologia , Monoéster Fosfórico Hidrolases/metabolismo , Fosfatase Ácida/metabolismo , Animais , Sistema Nervoso Central/enzimologia , Resistência a Medicamentos , Feminino , Fluoretos/farmacologia , Gânglios/citologia , Gânglios/enzimologia , Ligadura , Masculino , Microscopia Eletrônica , Terminações Nervosas/enzimologia , Nociceptores/enzimologia , Nervos Periféricos/fisiologia , Monoéster Fosfórico Hidrolases/antagonistas & inibidores , Ratos , Ratos Endogâmicos , Fluoreto de Sódio/farmacologia , Raízes Nervosas Espinhais/fisiologiaRESUMO
The presence of p53 and tissue transglutaminase (tTG) gene expressions was investigated in human normal and pathologic adrenal tissues with two aims (1) to determine the tissue content of p53 protein, its messenger ribonucleic acid (mRNA) and, especially, tTG mRNA which has not been previously reported and (2) to study possible differences in the coexpression of p53 and tTG in various adrenal disorders. Using Northern blot analysis, p53 and tTG mRNAs were detected in each adrenal tissue examined including 5 normal human adrenals, 6 aldosterone-producing adenomas, 3 Cushing's adenomas, 1 primary nodular adrenocortical hyperplasia causing Cushing's syndrome in an infant, 12 non-hyperfunctioning adrenocortical adenomas, and 4 adrenocortical carcinomas. The results showed a significant positive correlation between these two mRNAs in all adrenal tissues except adrenocortical carcinomas. Compared to normal adrenals, high p53 mRNA levels were observed in aldosterone-producing and Cushing's adenomas and, most markedly, in a tissue from a primary nodular adrenocortical hyperplasia. Also, Cushing's adenomas had significantly higher tTG mRNA contents. Immunohistochemistry for wild-type and mutant p53 protein showed numerous p53 positive cells with a strong nuclear staining in a tissue from a primary nodular adrenocortical hyperplasia, whereas the p53 positive cells were absent, except those with a faint nuclear staining, in all other adrenal tissues. However, all adrenal tissues showed detectable p53 contents by the more sensitive method of luminometric immunoassay (LIA). Using this method, aldosterone-producing adenomas exhibited significantly higher p53 contents than normal adrenal tissues. These observations may support potentially important roles for p53 and tTG in adrenal pathophysiology, especially in mechanisms which influence the evolution and/or progression of aldosterone-producing and Cushing's adenomas and, most probably, hyperplasias.
Assuntos
Glândulas Suprarrenais/patologia , Regulação da Expressão Gênica/genética , Genes p53/genética , Transglutaminases/genética , Neoplasias das Glândulas Suprarrenais/metabolismo , Aldosterona/metabolismo , Humanos , Imuno-Histoquímica , Proteínas de Neoplasias/genética , RNA Mensageiro/metabolismo , Proteína Supressora de Tumor p53/análiseRESUMO
In this prospective study the correlation of pathological with biological prognostic factors and serum tumor markers has been investigated in 574 patients with primary invasive breast cancer. The p53 protein and Bax level correlated positively with tumor size, lymph node status and histological grade. The serum levels of CEA, CA 15.3, TPA-M and TK correlated with tumor extent. There was a significant difference between pre- and postmenopausal breast cancer patients in serum levels of TPA-M and cytosol levels of Bax. Whether these correlations can help in predicting the prognosis of breast cancer by providing additional information with respect to the conventional factors, will have to be investigated by several years of careful clinical follow-up.
Assuntos
Biomarcadores Tumorais/sangue , Neoplasias da Mama/patologia , Neoplasias da Mama/sangue , Neoplasias da Mama/cirurgia , Antígeno Carcinoembrionário/sangue , Feminino , Humanos , Mucina-1/sangue , Estudos Prospectivos , Proteínas Proto-Oncogênicas c-bcl-2/sangue , Timidina Quinase/sangue , Antígeno Polipeptídico Tecidual/sangue , Proteína Supressora de Tumor p53/sangueRESUMO
It is well established that changes in fluid and electrolyte homeostasis may accompany and are likely to modify the clinical symptoms of alcohol withdrawal reactions. It was of obvious theoretical and practical interest, therefore, to investigate the changes in the secretion of hormones which regulate the fluid and electrolyte homeostasis [alpha-atrial natriuretic peptide (alpha-ANP), aldosterone (ALDO) and plasma renin activity (PRA)], together with the changes in the serum electrolytes (sodium, potassium) in male chronic alcoholic inpatients. The patients were transferred to the hospital because of severe alcohol withdrawal reactions. Blood samples were taken on Day 1 (severe withdrawal) and Day 10 (partial recovery from withdrawal) of hospitalization. The peptide and steroid hormones were measured with RIA (radioimmunoassay), while flame photometry was used to measure the electrolytes in the serum. At the time of hospital admission, there was an increased PRA and ALDO level observed. Ten days later, the elevated PRA and ALDO levels were greatly reduced and thus they were back to the normal range. In 60% of the patients, delirium tremens has gradually developed during the observation period. In these patients, an elevated level of alpha-ANP was observed at the time of hospital admission, i.e., days before actual onset of delirium tremens. It is concluded that the disturbed volume homeostasis and the consequently altered alpha-ANP secretion might be associated with and therefore used as an indicator of the onset of delirium tremens.
Assuntos
Delirium por Abstinência Alcoólica/sangue , Aldosterona/sangue , Fator Natriurético Atrial/sangue , Etanol/efeitos adversos , Renina/sangue , Síndrome de Abstinência a Substâncias/sangue , Adulto , Humanos , Masculino , Pessoa de Meia-Idade , Valores de ReferênciaRESUMO
The genuine marker enzyme of primary nociceptive neurons, thiamine monophosphatase (TMPase) has been localized in the substantia gelatinosa of the rat spinal cord by means of light-and electron microscopic histochemistry; localization of substance P has been studied by light-and and electron microscopic immunohistochemical methods. It has been shown that TMPase and substance P are located in two, regionally and structurally different populations of axon terminals. Substance P is contained both in A delta and in drC axons. In the postero-lateral funiculus of the white matter, substance P-positive axons establish axo-somatic synaptic contacts with large multipolar neurons of Cajal's interstitial nucleus.
Assuntos
Gânglios Espinais/enzimologia , Monoéster Fosfórico Hidrolases/análise , Substância P/análise , Animais , Axônios/enzimologia , Feminino , Histocitoquímica , Técnicas Imunoenzimáticas , Masculino , Microscopia Eletrônica , Monoéster Fosfórico Hidrolases/metabolismo , Ratos , Ratos Endogâmicos , Medula Espinal/enzimologiaRESUMO
This was the first time that authors detected se-S-100 and 5-SCD values with patients with malignant melanoma in Hungary. They examined the change of serum S-100 and 5-SCD value parallel. Sera were obtained with 184 melanoma patients 326 times. Patients were ranked into groups on the basis of clinical symptoms: free of symptoms and suffering from it (primary tumour, regional lymph node metastasis, soliter or multiplex distant metastasis). On the basis of the initial results the following have been found: S-100 protein and 5-SCD serum levels had no prognostic value in patients with primary melanoma. Patients without symptoms showed values around the normal level. There was significant difference in both markers between patients with or without symptoms. Significant differences were found between clinical stage I and II, as well as in clinical stage II and III. In the case of S-100 protein there was significant difference between the values of patients with soliter and multiplex distant metastasis.
Assuntos
Di-Hidroxifenilalanina/análogos & derivados , Melanoma/sangue , Proteínas S100/sangue , Di-Hidroxifenilalanina/sangue , Feminino , Humanos , Masculino , Melanoma/patologia , Metástase NeoplásicaAssuntos
Delirium por Abstinência Alcoólica/fisiopatologia , Alcoolismo/fisiopatologia , Sistema Nervoso Central/fisiopatologia , Desequilíbrio Hidroeletrolítico/fisiopatologia , Adulto , Delirium por Abstinência Alcoólica/sangue , Alcoolismo/sangue , Aldosterona/sangue , Fator Natriurético Atrial/metabolismo , Humanos , Masculino , Radioimunoensaio , Renina/sangue , Sódio/sangueRESUMO
BACKGROUND: The optimal treatment of choice for ACTH-producing pituitary adenomas is their complete removal by the transsphenoidal surgical approach. ACTH-producing pituitary adrenomas are, however, often small in size not detectable with neuro-imaging techniques, which may result in difficulties during their surgical removal. With the advent of rapid methods for plasma ACTH measurement, a few neurosurgical centers introduced intra-operative plasma ACTH determinations in peripheral and central blood samples to help improve the outcome of pituitary surgery in patients with Cushing's disease. METHOD: To evaluate the usefulness of this new method, we performed, under standardized conditions, intra-operative plasma ACTH measurements with a rapid immunochemiluminometric method at different stages of transsphenoidal pituitary surgery in 7 patients with Cushing's disease. FINDINGS: We found that from the beginning of anesthesia until the end of operation, ACTH concentrations in venous plasma were highly variable by both the rapid and the standard methods. In most cases the changes in venous plasma ACTH concentrations that occurred until the end of surgery failed to indicate the removal of the ACTH-producing pituitary adenoma. However, a more than 50% decrease of venous plasma ACTH concentrations by the rapid assay was observed 2 h after completion of the operation in all but one of the patients. As evidenced by a long-term hormonal and clinical remission, these changes in plasma ACTH levels in all patients were accompanied by a complete removal of the ACTH-producing pituitary adenoma. INTERPRETATION: These findings indicate a slow disappearance of ACTH from the circulation after a successful pituitary surgery in patients with Cushing's disease.
Assuntos
Adenoma/cirurgia , Hormônio Adrenocorticotrópico/sangue , Síndrome de Cushing/cirurgia , Endoscopia , Hipofisectomia , Monitorização Intraoperatória , Neoplasias Hipofisárias/cirurgia , Seio Esfenoidal/cirurgia , Adenoma/sangue , Adulto , Criança , Síndrome de Cushing/sangue , Feminino , Seguimentos , Humanos , Masculino , Neoplasia Residual/sangue , Neoplasias Hipofisárias/sangue , Complicações Pós-Operatórias/sangue , Valor Preditivo dos Testes , Resultado do TratamentoRESUMO
The role of p53 tumor suppressor gene in the pathomechanism of adrenal tumors was investigated by measuring p53 protein and its messenger ribonucleic acid (mRNA) in 12 normal human adrenals as well as in 56 adrenal tumors (7 aldosterone-producing adenomas, 5 adrenocortical adenomas causing Cushing's syndrome, 19 non-hyperfunctioning adrenocortical adenomas, 5 adrenocortical carcinomas, 12 pheochromocytomas, 3 myelolipomas, 4 ganglioneuromas and 1 hemangioma). The p53 protein concentration was significantly increased in aldosterone-producing adenomas (394+/-36 pg/mg cytosolic protein, mean+/-SE, vs 266+/-18 in normal human adrenals), whereas the concentration of this protein in Cushing's adenomas, non-hyperfunctioning adrenocortical adenomas, pheochromocytomas, and in all but one adrenocortical carcinomas was similar to that measured in normal human adrenal tissues. One adrenocortical carcinoma tissue showed very high p53 protein content (3000 pg/mg cytosolic protein). By contrast, myelolipomas (23+/-20) ganglioneuromas (43+/-15) and a hemangioma (11 pg/mg cytosolic protein) had very low p53 protein content. Northern blot analysis revealed the presence of p53 mRNA in each adrenal tissue examined with highest levels in aldosterone-producing and Cushing's adenomas. It is possible that the differences in p53 protein and/or mRNA contents reflect corresponding differences in the pathogenetic importance of p53 alterations in these types of adrenal tumors.